|
MAPKSP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58290047735932E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.97060187349052E-11 |
| Normal-vs-Stage2 |
9.171200E-04 |
| Normal-vs-Stage3 |
1.30610000037557E-07 |
| Normal-vs-Stage4 |
2.756500E-03 |
| Stage1-vs-Stage2 |
1.142420E-01 |
| Stage1-vs-Stage3 |
7.516400E-01 |
| Stage1-vs-Stage4 |
3.419000E-01 |
| Stage2-vs-Stage3 |
7.575600E-02 |
| Stage2-vs-Stage4 |
8.205400E-01 |
| Stage3-vs-Stage4 |
2.342400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03860031686054E-10 |
| Normal-vs-AfricanAmerican |
9.81949999978582E-07 |
| Normal-vs-Asian |
1.595160E-01 |
| Caucasian-vs-AfricanAmerican |
3.227600E-01 |
| Caucasian-vs-Asian |
9.729000E-01 |
| AfricanAmerican-vs-Asian |
7.377000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.65130173160833E-11 |
| Normal-vs-Female |
2.01790000042834E-07 |
| Male-vs-Female |
3.365200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.93940000409776E-08 |
| Normal-vs-Extreme_Weight |
1.22290000348357E-09 |
| Normal-vs-Obese |
1.56589999855683E-08 |
| Normal-vs-Extreme_Obese |
1.071440E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.445600E-01 |
| Normal_Weight-vs-Obese |
8.375000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.119200E-01 |
| Extreme_Weight-vs-Obese |
6.578600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.763400E-01 |
| Obese-vs-Extreme_Obese |
3.482400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.51170000000289E-05 |
| Normal-vs-Age(41-60Yrs) |
4.48399994912307E-09 |
| Normal-vs-Age(61-80Yrs) |
3.50299789175779E-11 |
| Normal-vs-Age(81-100Yrs) |
2.646100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.280600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.712600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.507400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.828990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.199800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.133400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.55440154875942E-11 |
| Normal-VS-Type2 PRCC |
1.31540001113706E-09 |
| Normal-VS-KIRP CIMP |
2.36509999999024E-05 |
| Normal-VS-Unclassified PRCC |
1.07920000003148E-06 |
| Type1 PRCC-VS-Type2 PRCC |
9.700200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.733400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.729000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.901000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.824400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.200400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.97339996857949E-09 |
| Normal-vs-N1 |
5.43069999969781E-07 |
| Normal-vs-N2 |
1.243220E-03 |
| N0-vs-N1 |
7.998400E-01 |
| N0-vs-N2 |
8.663800E-01 |
| N1-vs-N2 |
6.802000E-01 |
|
|
